Bioscience Animal Health PCL

Bioscience Animal Health PCL EBITDA per Share

The EBITDA per Share of Bioscience Animal Health PCL (BIS.BK) as of Oct 22, 2026 is 0.06 THB. In the previous year, EBITDA per Share was 0.30 THB — a change of -79.05% (lower).

EBITDA per Share

0.06THB

YoY

-79.05%

Last updated:

EBITDA per Share of Bioscience Animal Health PCL is 2025 0.06 THB. EBITDA per Share of Bioscience Animal Health PCL was 2024 0.30 THB. It decreases by -79.05% lower compared to the previous year.

The Bioscience Animal Health PCL EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.05 THB
Jan 1, 2019
0.09 THB
Jan 1, 2020
0.36 THB
Jan 1, 2021
0.31 THB
Jan 1, 2022
0.26 THB
Jan 1, 2023
0.22 THB
Jan 1, 2024
0.30 THB
Jan 1, 2025
0.06 THB
The Bioscience Animal Health PCL EBITDA per Share history
YEAREBITDA per ShareYoY
0.06THB-79.05%
0.30THB+38.88%
0.22THB-16.76%
0.26THB-14.76%
0.31THB-14.28%
0.36THB+309.17%
0.09THB+91.46%
0.05THB-45.98%
0.08THB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioscience Animal Health PCL Stock analysis

What does Bioscience Animal Health PCL do? Bioscience Animal Health PCL manufactures, imports, and distributes medical supplies, tools, equipment, and products for livestock and pets. The company focuses on specialist veterinarian-selected products to improve animal health, offering antibiotics like Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin, as well as injections such as Zuprevo, Nuflor, Ceva, and Enzaprost. It also provides BiSMiX B-Series, BiSMiX SD Series, mold inhibitors, water-soluble products, and vaccines. Services include farm advisory, disease prevention, serological diagnosis, biosafety management, feed analysis, and personnel training programs. The company's revenue comes from selling medical supplies, equipment, and products to livestock and pet care providers. Key buyers include farms, veterinary clinics, and animal health facilities that require antibiotics, injections, and specialized animal health solutions. The firm targets segments focused on livestock and pet health through its product portfolio and advisory services, emphasizing veterinarian-approved solutions for improved animal welfare and farm efficiency. Bioscience Animal Health PCL's product lines are designed to address specific veterinary needs, with brands like BiSMiX B-Series and BiSMiX SD Series being central to its offerings. The company leverages its distribution network to supply both direct and indirect clients across the animal health sector, ensuring access to critical veterinary products and services that support disease prevention and farm management. Bioscience Animal Health PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioscience Animal Health PCL stock

EBITDA per Share of Bioscience Animal Health PCL is 0.06 THB in 2025.

EBITDA per Share of Bioscience Animal Health PCL changed from 0.30 THB to 0.06 THB, representing a -79.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Bioscience Animal Health PCL since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Bioscience Animal Health PCL

All Key Metrics — Bioscience Animal Health PCL